Immunosuppressive Regimen for Xenotransplantation
Partial Protocol Preview
This section provides a glimpse into the protocol.
The remaining content is hidden due to licensing restrictions, but the full text is available at the following link:
Access Free Full Text.
Corresponding Organization : Vanderbilt University
Other organizations : Stevens Institute of Technology
Variable analysis
- Cobra venom factor (CVF, 1 mg; Sigma-Aldrich) to deplete complement activity
- Intravenous diphenhydramine (50 mg; West-Ward) and methylprednisolone (1 g; Pfizer) to limit the inflammatory response associated with CVF
- Intravenous tacrolimus (5 mg; Astellas) and mycophenolate (500 mg; Genentech) prior to reperfusion and re-dosed every 12 hours
- Methylprednisolone (125 mg; Pfizer) re-administered every 8 hours after the initial dose
- Outcome of xeno-support of human lungs
- Immunosuppression regimen informed by current practices in clinical transplantation, and previously described for use in xeno-support of human lungs
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!